StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Teva Pharma (TEVA) Weighing Options for Branded Generics Unit to Cut Debt - Bloomberg
February 13, 2017 11:35 AM
(Updated - February 13, 2017 11:41 AM EST)Teva Pharma (NYSE: TEVA) is weighing options for its ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Hot M&A
Mergers and Acquisitions
Rumors
Spinoffs
Next Articles
Teva Pharma (TEVA) PT Lowered to $40 at Maxim Group
February 13, 2017 1:14 PM
Teva Pharma (TEVA) volatility comes in after solid Q4 and outlook
February 13, 2017 11:26 AM
Teva seeks CEO with pharma background to lead recovery efforts
February 13, 2017 10:34 AM
Teva Pharma (TEVA) Tops Q4 EPS by 2c; Reaffirms
February 13, 2017 6:43 AM
Teva Reports Full Year and Fourth Quarter 2016 Financial Results
February 13, 2017 6:42 AM